Richard A. Heyman, Director at Oric Pharmaceuticals, Inc. (ORIC), sold 13,100 shares at $12.02 ($157K) on 2026-07-24, disclosed to the SEC on 2026-07-28.
Scheduled sale ($157k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.02 | 6,100 | $73K | 46.6% |
| 2 | $12.02 | 7,000 | $84K | 53.4% |
| Total | $12.02 avg | 13,100 | $157K | 100% |
| Filing → |
| ELVN | SELL | 2026-01-22 | $33K | — | Filing → |
| ORIC | SELL | 2026-01-20 | $80K | — | Filing → |
| ELVN | SELL | 2026-01-12 | $656K | — | Filing → |